✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Estetrol is an investigational drug.
There have been 24 clinical trials for Estetrol. The most recent clinical trial was a Phase 3 trial, which was initiated on September 27th 2019.
The most common disease conditions in clinical trials are Breast Neoplasms, Prostatic Neoplasms, and Infections. The leading clinical trial sponsors are Estetra, Pantarhei Bioscience, and Pantarhei Oncology B.V.
There are one hundred and six US patents protecting this investigational drug and eight hundred and ninety international patents.
Recent Clinical Trials for Estetrol
|Single and Multiple Intravenous Administrations of Estetrol (E4) in Healthy Adult Volunteers||NEURALIS s.a.||Phase 1|
|Effect of Estetrol Monohydrate (E4) on QTc Interval||Estetra||Phase 1|
|Safety, Compliance and Pharmacokinetics of Estetrol Monohydrate/Drospirenone 15/3 mg in Post-menarchal Female Adolescents||Estetra||Phase 3|
Top disease conditions for Estetrol
Top clinical trial sponsors for Estetrol
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Estetrol||See Plans and Pricing||Synthesis of estetrol via estrone derived steroids||Donesta Bioscience B.V. (Zeist, NL)||See Plans and Pricing|
|Estetrol||See Plans and Pricing||Neuroprotection and myelin repair using Nestorone.RTM.||The Population Council, Inc. (New York, NY)||See Plans and Pricing|
|Estetrol||See Plans and Pricing||Gene fusions and gene variants associated with cancer||LIFE TECHNOLOGIES CORPORATION (Carlsbad, CA)||See Plans and Pricing|
|Estetrol||See Plans and Pricing||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||See Plans and Pricing|
|Estetrol||See Plans and Pricing||Tablet containing dehydroepiandrosterone (DHEA)||PANTARHEI BIOSCIENCE B.V. (Zeist, NL)||See Plans and Pricing|
|Estetrol||See Plans and Pricing||Apparatus and methods for drug delivery using multiple reservoirs||CLEARSIDE BIOMEDICAL, INC. (Alpharetta, GA)||See Plans and Pricing|
|Estetrol||See Plans and Pricing||Bioerodible implant for long-term drug delivery and associated methods of manufacture and use||GESEA BIOSCIENCES INC. (San Luis Obispo, CA)||See Plans and Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Estetrol||Austria||AT469165||2022-11-08||See Plans and Pricing|
|Estetrol||Australia||AU2003279624||2022-11-08||See Plans and Pricing|
|Estetrol||Canada||CA2505190||2022-11-08||See Plans and Pricing|
|Estetrol||China||CN100343269||2022-11-08||See Plans and Pricing|
|Estetrol||China||CN1735627||2022-11-08||See Plans and Pricing|
|Estetrol||Cyprus||CY1110237||2022-11-08||See Plans and Pricing|
|Estetrol||Germany||DE60332754||2022-11-08||See Plans and Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|